// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Utilisation of genetic testing in an adult congenital heart disease clinic

Sadaf Raza - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

Increasing the diagnostic yield of the 100 000 genomes project for participants with congenital heart disease

Stephanie Baross - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

Alivecor detecting arrythmias in a single centre adult congenital population

John William Pennington - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

Peri procedural tamponade during transcatheter arotic valve insertion tavi standard vs balloon tipped temporary pacing wires a 3 cyle audit

Skanda Rajasundaram - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

N/A

Arrhythmia as a herald sign for cardiac lymphoma in a young and immunocompetent patient

Tom Wardill - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Arrhythmia

N/A

Mavacamten eligibility in patients with hypertrophic cardiomyopathy attending cardiology clinic in essex uk

Sarina Vara - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

MYK 461

Utilisation of a combined obstetric cardiology clinic in a uk tertiary cardiology centre

Shue Jun Cheng - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Raising the suspicion of adult congenital heart disease achd in symptomatic patients without abnormal initial echocardiographic findings a case report

Ahmed Hussein - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

Data independent acquisition mass spectrometry in severe rheumatic heart disease rhd identifies a proteomic signature showing ongoing inflammation and effectively classifying rhd cases

Jing Yang - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Rheumatic heart disease

N/A

Outcomes following acute myocardial injury and type 2 myocardial infarction in patients with and without coronary artery disease

Caelan Taggart - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Shockwave intravascular lithotripsy ivl for calcified coronary lesions a real world multicentre european study with long term follow up

Waseem Raja - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Long term clinical outcomes of percutaneous coronary intervention versus no intervention in patients with chronic total occlusion a meta analysis of randomised trials

Abdalazeem Ibrahem - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic total occlusion

N/A

Development of novel cost effective cmr conditional 3d printed cardiac phantom for simulated right heart catherisation

Enhui Yong - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

A retrospective chart review of all patients with an out of hospital cardiac arrest ooh ca presenting to the royal berkshire hospital rbh nhs foundation trust 2018 2021 post resuscitation care based on the cardiovascular disease outcomes strategy drives improved patient survival

Liza Keating - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Early discharge for low risk stemi patients after successful primary pci 8 week follow up data

Aditya Mukherjee - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Use of sirolimus coated balloon in de novo small vessel coronary lesions in acute coronary syndrome long term follow up from a single centre registry

Maria Zakai - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

Rapacan

Can waiting times for urgent cabg be reduced to fall within national recommendations insights from a large tertiary cardiac center

Ahmed Elamin - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Real world outcomes of ifr guided pci in a single centre

Md Imran Hossain - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Adenosine

4 metre gait speed as a predictor of 5 year survival after acute myocardial infarction a prospective cohort study

Pranev Sharma - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Invasive coronary physiology assessment safety of pressure wire study as a diagnostic tool at a district general hospital

Sotirios Dardas - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved